Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence

Links shared publicly online about this topic.

  • 667
    total visits

Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence

medicalnewstoday.com —

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that projected improvements in recurrence-free survival and an only modes

View full resource at medicalnewstoday.com

Tags: Cancer, Ovarian Cancer, Disease and Condition, Healthcare, Pharma, Women's Health, disease

  • Share

Most Recently Shared on December 9, 2010 at 9:27 pm By:

OvarianCancer_ Ovarian Cancer OW

Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence:... http://mnt.to/f/3NP9

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Ovarian Cancer MNT Ovarian Cancer

Advertisement